Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 11, 2020
Ajinomoto Bio-Pharma announced the formation of its External Advisory Board (EAB) to provide insight into industry trends and high-level advice to the Company’s leadership team.
read more
Wednesday, March 11, 2020
OptimizeRx has secured two additional enterprise-level engagements, expanding access for two clients across the entire OptimizeRx platform.
read more
Wednesday, March 11, 2020
The FDA and the FTC issued warning letters to seven companies for selling fraudulent COVID-19 products.
read more
Wednesday, March 11, 2020
HitGen and Kaken Pharmaceutical have entered into a license agreement to develop a novel class of drugs.
read more
Aldevron has hired Vijay Surapaneni as its Vice President of Biomanufacturing Operations. This is a new position and is a part of the senior management team.
read more
Clearside Biomedical announced Arctic Vision has acquired an exclusive license for the commercialization and development of XIPERE in Greater China and South Korea.
read more
Thermo Fisher Scientific has signed an agreement with Janssen Biotech to co-develop a companion diagnostic (CDx) in oncology.
read more
Sinclair Research will officially open its 20,000-square-foot laboratory expansion later this spring.
read more
UPM Biomedicals and Nichirei Biosciences have signed an agreement on 1 March 2020 to offer the full range of UPM cell culture products to life sciences researchers in Japan.
read more
The FDA finalized guidance for industry, “Competitive Generic Therapies,” which describes the process that generic drug applicants should follow to request designation of a drug as a CGT and the criteria for that designation.
read more
BioStem Life Sciences announced the buildout of a brand new R&D lab.
read more
ImprimisRx has agreed to a product supply agreement with EyeCare Services Partners (ESP).
read more
Amneal Pharmaceuticals announced Thursday Tasos Konidaris was appointed as senior vice president, chief financial officer, effective March 12.
read more
WuXi AppTec announced the company's Wuhan site has resumed operations, in compliance with local regulations and global COVID-19 health and safety guidelines.
read more
Emergent BioSolutions will collaborate with Novavax to support bringing into the clinic Novavax’s novel experimental vaccine candidate to protect against coronavirus disease (COVID-19).
read more